PROF

Healthcare Medical Devices

Profound Medical Corp.

$6.03

+0.19 +3.25% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 1:04 PM ET	6.03

Key Stats

Market Cap

220.29M

Avg Volume

121,279

EPS

-$0.99

52W High

$8.95

52W Low

$4.80

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-10.26

P/B Ratio

4.42

P/S Ratio

11.54

EV/EBITDA

-5.23

EV/Revenue

9.56

Margins

Gross Margin 71.8%

Operating Margin (445.7%)

Net Margin (171.6%)

EBITDA Margin (182.7%)

Growth & Returns

Revenue Growth (YoY)

12.3%

Return on Equity

(73.5%)

Return on Assets

(39.5%)

Liquidity & Leverage

Current Ratio

6.46

Quick Ratio

5.25

Debt / Equity

0.15

Total Cash

38.27M

Total Debt

7.38M

About

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.